Fay CJ - Search Results

1

Harnessing the immune system in the treatment of cutaneous T cell lymphomas.

Fay CJ, Awh KC, LeBoeuf NR, Larocca CA. Fay CJ, et al. Front Oncol. 2023 Jan 12;12:1071171. doi: 10.3389/fonc.2022.1071171. eCollection 2022. Front Oncol. 2023. PMID: 36713518 Free PMC article.

2

Keys to Achieving Clinically Important Weight Loss: Perceptions of Responders and Nonresponders in the Clinic and Community Approaches to Healthy Weight Trial.

Fay C, Castro I, Sierra Velez D, Ruggiero CF, O'Connor G, Perkins M, Luo M, Sharifi M, Neri Mini F, Taveras EM, Kuhlthau K, Fiechtner L. Fay C, et al. Child Obes. 2023 Dec;19(8):507-514. doi: 10.1089/chi.2022.0112. Epub 2022 Oct 28. Child Obes. 2023. PMID: 36315223 Free PMC article.

3

Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies.

Fay CJ, Jakuboski S, Mclellan B, Allais BS, Semenov Y, Larocca CA, LeBoeuf NR. Fay CJ, et al. Am J Clin Dermatol. 2023 Sep;24(5):765-785. doi: 10.1007/s40257-023-00790-8. Epub 2023 Jul 3. Am J Clin Dermatol. 2023. PMID: 37395930 Free PMC article. Review.

4

Cutaneous immune-related adverse events from immune checkpoint inhibitor therapy: Moving beyond "maculopapular rash".

Allais BS, Fay CJ, Kim DY, Semenov YR, LeBoeuf NR. Allais BS, et al. Among authors: fay cj. Immunol Rev. 2023 Sep;318(1):22-36. doi: 10.1111/imr.13257. Epub 2023 Aug 15. Immunol Rev. 2023. PMID: 37583051 Review.

5

Edema of the face and extremities secondary to pemetrexed.

Doyle T, Fay CJ, Pisano C, LeBoeuf NR. Doyle T, et al. Among authors: fay cj. JAAD Case Rep. 2023 May 18;38:20-22. doi: 10.1016/j.jdcr.2023.05.011. eCollection 2023 Aug. JAAD Case Rep. 2023. PMID: 37600745 Free PMC article. No abstract available.

6

Diffuse Cutaneous Aphthosis After Combined Targeted Cancer Therapies and Responsive to Pentoxifylline.

Larocca CA, Fay CJ, Hirner JP, Meyerhardt JA, Cleary JM, Dewan AK, LeBoeuf NR. Larocca CA, et al. Among authors: fay cj. JAMA Dermatol. 2023 Oct 1;159(10):1136-1139. doi: 10.1001/jamadermatol.2023.2649. JAMA Dermatol. 2023. PMID: 37610794 Free PMC article.

7

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis.

Fay CJ, Iriarte C, Moslehi D, Sheets AR, LeBoeuf NR. Fay CJ, et al. JAAD Case Rep. 2023 Jul 22;39:70-73. doi: 10.1016/j.jdcr.2023.07.010. eCollection 2023 Sep. JAAD Case Rep. 2023. PMID: 37635862 Free PMC article. No abstract available.

8

Treatment-refractory cutaneous Rosai-Dorfman disease responsive to oral methotrexate and topical trametinib.

Fay CJ, Moslehi D, Iriarte C, Dang TM, Virgen CA, Russell-Goldman E, LeBoeuf NR. Fay CJ, et al. JAAD Case Rep. 2023 Jul 7;39:74-77. doi: 10.1016/j.jdcr.2023.06.038. eCollection 2023 Sep. JAAD Case Rep. 2023. PMID: 37650013 Free PMC article. No abstract available.

9

Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma.

Fay CJ, Iriarte C, Moslehi D, Lam J, Katsyv I, LeBoeuf NR. Fay CJ, et al. JAAD Case Rep. 2023 Aug 1;40:1-3. doi: 10.1016/j.jdcr.2023.07.024. eCollection 2023 Oct. JAAD Case Rep. 2023. PMID: 37663892 Free PMC article. No abstract available.

10

Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition.

Leung BW, Fay CJ, Said JT, Sheets AR, Lian CG, Brown JR, Castillo JJ, Sarosiek S, Flynn C, LeBoeuf NR. Leung BW, et al. Among authors: fay cj. Leuk Lymphoma. 2023 Dec;64(12):2047-2050. doi: 10.1080/10428194.2023.2245091. Epub 2023 Sep 6. Leuk Lymphoma. 2023. PMID: 37671695 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters